Table 3 Sex ratios of adverse drug event reports in VigiBase among 59 drugs with sex-biased ADRs
From: Sex differences in pharmacokinetics predict adverse drug reactions in women
WHO ATC category | Drug name/PK biasa | ADR bias | VB ratiob | ADR-VB relation |
|---|---|---|---|---|
Alimentary tract, metabolism | Liraglutide | Females | 1.79 | Concordant |
Ranitidine | Males | 1.52 | Discordant1 | |
Rosiglitazone | Females | 0.79 | Discordant1 | |
Blood and blood forming organ | Heparin | Females | 0.92 | Discordant2 |
Aspirin | Females | 0.85 | Discordant2 | |
Warfarin | Females | 0.91 | Discordant2 | |
Clopidogrel | Females | 0.69 | Discordant2 | |
Dabigatran | Females | 0.93 | Discordant2 | |
Cardiovascular system | Torasemide | Females | 1.15 | Discordant2 |
Pravastatin | Females | 1.13 | Discordant2 | |
Amlodipine | Females | 1.41 | Concordant | |
Digoxin | Females | 1.26 | Concordant | |
Verapimil | Females | 1.56 | Concordant | |
Aliskiren | Females | 1.27 | Concordant | |
Losartan | Males | 1.41 | Discordant1 | |
Propranolol | Females | 1.72 | Concordant | |
Dofetilide | Females | 0.92 | Discordant2 | |
Genito-urinary system, sex hormones | Mirabegron | Females | 1.95 | Concordant |
Darifenacin | Females | 2.48 | Concordant | |
Trospium | Females | 2.14 | Concordant | |
Systemic hormonal preparations | Prednisone | Females | 1.17 | Discordant2 |
Anti-infectives | Levofloxacin | Females | 1.26 | Concordant |
Erythromycin | Females | 1.70 | Concordant | |
Voriconazole | Females | 0.65 | Discordant1 | |
Antineoplastics, immunomodulators | Cyclosporin | Neither | 1.25 | Discordant1 |
Fluorouracil | Females | 1.00 | Discordant2 | |
Paclitaxel | Females | 2.66 | Concordant | |
Capecitabine | Females | 1.77 | Concordant | |
Infliximab | Females | 1.51 | Concordant | |
Adalimumab | Females | 2.02 | Concordant | |
Anesthetics, analgesics | Morphine | Females | 1.57 | Concordant |
Oxycodone | Females | 1.01 | Discordant2 | |
Buprenorphine | Females | 1.61 | Concordant | |
Tramadol | Females | 1.71 | Concordant | |
Zolmitriptan | Females | 5.14 | Concordant | |
Ketamine | Males | 1.07 | Discordant2 | |
Anti-epileptics, anti-Parkinson’s | Carbamazepine | Females | 1.26 | Concordant |
Gabapentin | Females | 1.84 | Concordant | |
Perampanel | Females | 1.18 | Discordant2 | |
Pramipexole | females | 1.19 | Discordant2 | |
Psycholeptics | Olanzapine | Females | 0.92 | Discordant2 |
Clozapine | Males | 0.61 | Concordant | |
Risperidone | Females | 0.53 | Discordant1 | |
Aripiprazol | Females | 1.27 | Concordant | |
Diazepam | Females | 1.17 | Discordant2 | |
Zolpidem | Females | 1.48 | Concordant | |
Eszopiclone | Females | 1.85 | Concordant | |
Psychoanaleptics | Imipramine | Females | 1.61 | Concordant |
Nortriptyline | Females | 2.10 | Concordant | |
Fluoxetine | Females | 2.29 | Concordant | |
Citalopram | Females | 1.95 | Concordant | |
Sertraline | Females | 2.00 | Concordant | |
Bupropion | Females | 1.79 | Concordant | |
Methylphenidate | Females | 0.47 | Discordant1 | |
Antiparasitics | Primaquine | Females | 0.55 | Discordant1 |
Respiratory | Terfenadine | Females | 1.66 | Concordant |
Fexofenadine | Females | 2.05 | Concordant | |
Miscellaneous | MDMA | females | 0.43 | Discordant1 |
Cannabis | females | 0.51 | Discordant1 |